OBJECTIVE: The -174 interleukin (IL)-6 gene polymorphism has been proposed as a risk factor for type 2 diabetes, but data are conflicting. Because white fat is a major source of IL-6 in resting individuals, we tested the hypothesis that BMI modifies the association among the IL-6 genotype, insulin resistance (IR) (measured using the homeostasis model), and risk of diabetes. RESEARCH METHODS AND PROCEDURES: Outcomes were assessed in a community-based cohort study of 1525 adults (mean age, 55.6 years; 753 men), who participated in the Framingham Offspring Study during the 1991 to 1995 examinations. RESULTS: We found a significant interaction between IL-6 genotype and BMI on levels of IR in men (p < 0.0001), with obese homozygotes for the minor C allele being most resistant. The IL-6-BMI interaction was not significant (p = 0.46) in women. Among men with the CC genotype, increasing BMI was associated with increased prevalence of diabetes [odds ratio (OR) per unit increase in BMI, 1.30; 95% confidence interval (CI), 1.11 to 1.50] but not among those with the GG (OR, 1.10; 95% CI, 0.98 to 1.22) or GC genotype (OR, 1.05; 95% CI, 0.97 to 1.14). DISCUSSION: The -174 IL-6 promoter polymorphism modifies the association of obesity with IR and diabetes risk in men. Weight loss regimens targeted at reducing the risk of diabetes may be of particular benefit for men with a -174 IL-6 CC genotype.
OBJECTIVE: The -174 interleukin (IL)-6 gene polymorphism has been proposed as a risk factor for type 2 diabetes, but data are conflicting. Because white fat is a major source of IL-6 in resting individuals, we tested the hypothesis that BMI modifies the association among the IL-6 genotype, insulin resistance (IR) (measured using the homeostasis model), and risk of diabetes. RESEARCH METHODS AND PROCEDURES: Outcomes were assessed in a community-based cohort study of 1525 adults (mean age, 55.6 years; 753 men), who participated in the Framingham Offspring Study during the 1991 to 1995 examinations. RESULTS: We found a significant interaction between IL-6 genotype and BMI on levels of IR in men (p < 0.0001), with obese homozygotes for the minor C allele being most resistant. The IL-6-BMI interaction was not significant (p = 0.46) in women. Among men with the CC genotype, increasing BMI was associated with increased prevalence of diabetes [odds ratio (OR) per unit increase in BMI, 1.30; 95% confidence interval (CI), 1.11 to 1.50] but not among those with the GG (OR, 1.10; 95% CI, 0.98 to 1.22) or GC genotype (OR, 1.05; 95% CI, 0.97 to 1.14). DISCUSSION: The -174 IL-6 promoter polymorphism modifies the association of obesity with IR and diabetes risk in men. Weight loss regimens targeted at reducing the risk of diabetes may be of particular benefit for men with a -174 IL-6 CC genotype.
Authors: Patricia C Underwood; Bindu Chamarthi; Jonathan S Williams; Bei Sun; Anand Vaidya; Benjamin A Raby; Jessica Lasky-Su; Paul N Hopkins; Gail K Adler; Gordon H Williams Journal: Metabolism Date: 2011-11-08 Impact factor: 8.694
Authors: Stephan W Barth; Tatiana C L Koch; Bernhard Watzl; Helmut Dietrich; Frank Will; Achim Bub Journal: Eur J Nutr Date: 2011-10-25 Impact factor: 5.614
Authors: Mireia Junyent; Donna K Arnett; Michael Y Tsai; Edmond K Kabagambe; Robert J Straka; Michael Province; Ping An; Chao-Qiang Lai; Laurence D Parnell; Jian Shen; Yu-Chi Lee; Ingrid Borecki; Jose M Ordovás Journal: J Nutr Date: 2009-03-25 Impact factor: 4.798
Authors: Gary W Beecham; Eden R Martin; Yi-Ju Li; Michael A Slifer; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance Journal: Am J Hum Genet Date: 2009-01 Impact factor: 11.025
Authors: James B Meigs; Alisa K Manning; Josée Dupuis; Chunyu Liu; Jose C Florez; L Adrienne Cupples Journal: Obesity (Silver Spring) Date: 2008-07-24 Impact factor: 5.002
Authors: Joel Faintuch; Patricia C Marques; Luiz A Bortolotto; Jacob J Faintuch; Ivan Cecconello Journal: Obes Surg Date: 2008-04-03 Impact factor: 4.129